Central Government Health Scheme Blood Lancets and Anti-AB Blood Grouping Reagent Tender India 2026

Tender Overview

The Central Government Health Scheme (CGHS) invites bids for general blood bank reagents, specifically Blood Lancets and Anti-AB Blood Grouping Reagent (Q2) categories. The tender emphasizes MDR 2017 compliance, CDSCO/NIB approvals, and valid drug licenses under the Drugs and Cosmetics Act. Bid submissions require furnishing test reports, manufacturing certifications, and license validity, with an advance sample option for buyer approval prior to supply. The procurement integrates packaging, labeling, and shelf-life obligations, ensuring reagents demonstrate high sensitivity, specificity, and clear agglutination reactions for true antigen presence or absence. A MSME/NSIC EMD exemption clause is referenced in related terms, indicating potential vendor eligibility benefits. The scope prioritizes CDSCO-compliant blood grouping reagents that do not hemolyze cells and provide observable agglutination results under standard storage conditions. This is a specialized healthcare procurement opportunity within the Indian government framework, focusing on quality control and traceability in blood banks. The unique sourcing criteria include packaging inserts, kit-level certifications, and supplier responsibility for advance sampling if requested.

Technical Specifications & Requirements

• Product information: Lancet cap, plastic handle, needle gauge details to be supplied; ready-to-use reagents with antibodies for A and B antigens on RBCs; dropper provided; reagents must not cause rouleaux.
• Standards & licenses: MDR 2017 compliance; valid Drugs and Cosmetic Act 1940 license; ** CDSCO/NIB approvals** for blood bank reagents; manufacturing unit certification; MDR test reports.
• Performance & quality: clear agglutination for antigen-positive cells; absence of agglutination for antigen-negative cells; shelf-life data and storage temperature specifications; packing type and pack size; packaging insert included; advance sample option available.
• Documentation: submission of all certifications, licenses, and test reports with bid; adherence to labeling and appearance standards.

Terms, Conditions & Eligibility

• EMD details: Not explicitly stated; MSME/NSIC exemption may apply if registered, with certificate enclosed.
• Delivery & supply: Minimum shelf life must be stated at delivery; ready-to-use reagents must meet specified quality standards.
• Documentation: GST registration, PAN, experience certificates, financial statements, EMD/SD, OEM authorizations, and technical bid documents as applicable to the buyer’s requirements.
• Advance samples: Optional agreement to provide advance sample for buyer approval prior to commencement of supply.
• Penalties/conditions: Compliance with MDR and Drug Act licenses; mandatory test reports; packaging/insertion requirements.